137 related articles for article (PubMed ID: 10744748)
1. Gab-1-mediated IGF-1 signaling in IRS-1-deficient 3T3 fibroblasts.
Winnay JN; BrĂ¼ning JC; Burks DJ; Kahn CR
J Biol Chem; 2000 Apr; 275(14):10545-50. PubMed ID: 10744748
[TBL] [Abstract][Full Text] [Related]
2. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.
BrĂ¼ning JC; Winnay J; Cheatham B; Kahn CR
Mol Cell Biol; 1997 Mar; 17(3):1513-21. PubMed ID: 9032279
[TBL] [Abstract][Full Text] [Related]
3. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation.
Lingohr MK; Dickson LM; McCuaig JF; Hugl SR; Twardzik DR; Rhodes CJ
Diabetes; 2002 Apr; 51(4):966-76. PubMed ID: 11916914
[TBL] [Abstract][Full Text] [Related]
4. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
Mur C; Valverde AM; Kahn CR; Benito M
Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
[TBL] [Abstract][Full Text] [Related]
5. Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling.
Tsuruzoe K; Emkey R; Kriauciunas KM; Ueki K; Kahn CR
Mol Cell Biol; 2001 Jan; 21(1):26-38. PubMed ID: 11113178
[TBL] [Abstract][Full Text] [Related]
6. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
Kim B; Cheng HL; Margolis B; Feldman EL
J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124
[TBL] [Abstract][Full Text] [Related]
7. The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS. Modulation by insulin growth factor-I (IGF) and enhanced IGF-I signaling.
Beitner-Johnson D; Blakesley VA; Shen-Orr Z; Jimenez M; Stannard B; Wang LM; Pierce J; LeRoith D
J Biol Chem; 1996 Apr; 271(16):9287-90. PubMed ID: 8621590
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells.
Jackson JG; White MF; Yee D
J Biol Chem; 1998 Apr; 273(16):9994-10003. PubMed ID: 9545345
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of insulin receptor substrates in the anti-apoptotic function of insulin-like growth factor-1 and insulin.
Tseng YH; Ueki K; Kriauciunas KM; Kahn CR
J Biol Chem; 2002 Aug; 277(35):31601-11. PubMed ID: 12082100
[TBL] [Abstract][Full Text] [Related]
10. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
[TBL] [Abstract][Full Text] [Related]
11. Role of IRS-3 in the insulin signaling of IRS-1-deficient brown adipocytes.
Arribas M; Valverde AM; Benito M
J Biol Chem; 2003 Nov; 278(46):45189-99. PubMed ID: 12944402
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
Kurihara S; Hakuno F; Takahashi S
Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
[TBL] [Abstract][Full Text] [Related]
14. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
Valverde AM; Lorenzo M; Pons S; White MF; Benito M
Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse.
Richards RG; Walker MP; Sebastian J; DiAugustine RP
J Biol Chem; 1998 May; 273(19):11962-9. PubMed ID: 9565625
[TBL] [Abstract][Full Text] [Related]
16. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
17. Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinositol 3-kinase activation.
Harada S; Smith RM; Smith JA; White MF; Jarett L
J Biol Chem; 1996 Nov; 271(47):30222-6. PubMed ID: 8939974
[TBL] [Abstract][Full Text] [Related]
18. Growth factor-specific regulation of insulin receptor substrate-1 expression in MCF-7 breast carcinoma cells: effects on the insulin-like growth factor signaling pathway.
Lassarre C; Ricort JM
Endocrinology; 2003 Nov; 144(11):4811-9. PubMed ID: 12960057
[TBL] [Abstract][Full Text] [Related]
19. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes.
Boney CM; Gruppuso PA; Faris RA; Frackelton AR
Mol Endocrinol; 2000 Jun; 14(6):805-13. PubMed ID: 10847583
[TBL] [Abstract][Full Text] [Related]
20. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells.
Ariga M; Nedachi T; Akahori M; Sakamoto H; Ito Y; Hakuno F; Takahashi S
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]